{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:19:03Z","timestamp":1792790343949,"version":"4.5.0"},"reference-count":51,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"\n Importance<\/jats:title>\n Radiotherapy for breast cancer exposes the heart to incidental radiation, and historical data have shown a dose-dependent increase in associated cardiac events. Although whole-heart dose metrics are commonly used for risk assessment, emerging evidence suggests that dose to the left anterior descending coronary artery (LAD) may better capture risk.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To compare the ability of heart and LAD radiation dose metrics to predict cardiac risk after breast radiotherapy.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n \n This was a cross-sectional study of patients with breast cancer who were treated with either 3-dimensional conformal or intensity-modulated radiotherapy from 2008 to 2018 at a tertiary care center in Canada. The primary analysis included patients with left-sided breast cancer. Cardiac events were assessed using longitudinal follow-up data. Dosimetry was derived from computed tomography plans using automated segmentation and converted to equivalent dose in 2-Gy fractions (EQD\n 2<\/jats:sub>\n ). Data were analyzed from September 2024 to April 2026.\n <\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Adverse cardiac events defined as myocardial infarction or hospital admission or emergency department visit for unstable angina (ie, acute coronary syndrome), arrhythmia, heart failure, pericarditis, or myocarditis. The incidence of coronary angiography and coronary revascularization was also captured as coronary artery disease (CAD). Discrimination for dose metrics was performed with receiver operator characteristic curves and competing-risks regression (Fine and Gray), adjusted for cardiovascular risk factors.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The analysis included 4908 patients with breast cancer of whom 2223 had left-sided breast cancer. During a median (IQR) follow-up period of 10.8 (8.4-13.1) years, cumulative incidence of cardiac event or CAD was 5.0 (95% CI, 4.1-6.0) at 10 years. A data-driven cut point analysis identified 12 Gy EQD\n 2<\/jats:sub>\n as the maximum LAD dose that best stratified risk. Among patients with left-sided breast cancer, maximum LAD dose (concordance [C] index, 0.58; 95% CI, 0.52-0.64) discriminated better than mean heart dose (C index, 0.53; 95% CI, 0.47-0.60). In multivariable analysis, maximum LAD of 12 Gy or greater was independently associated with higher cardiac risk (subdistribution hazard ratio = 1.81; 95% CI, 1.04-3.16;\n P<\/jats:italic>\n = .04), whereas mean heart dose of 2 Gy or greater was not associated (\n P<\/jats:italic>\n = .99). For clinical context, the 12-Gy EQD\n 2<\/jats:sub>\n for maximum LAD dose corresponds to a physical dose of approximately 10.5 Gy for 42.5 Gy in 16 fractions and 7 Gy for 26 Gy in 5 fractions.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cross-sectional study of heart-sparing breast radiotherapy, LAD dose was associated with cardiac events, whereas whole-heart metrics was not. These findings support LAD-based planning and respiratory motion management to reduce long-term cardiovascular risk in patients with breast cancer undergoing radiotherapy.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaoncol.2026.2066","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:35:09Z","timestamp":1783006509000},"page":"931","source":"Crossref","is-referenced-by-count":5,"title":["Cardiac Risk After Heart-Sparing Breast Radiotherapy"],"prefix":"10.1001","volume":"12","author":[{"given":"Sarah","family":"Quirk","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Oncology, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn M.","family":"Atkins","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Logie","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J. H.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Guthier","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond H.","family":"Mak","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E. G.","family":"Warren","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mass General Brigham Cancer Institute and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Ramin","sequence":"additional","affiliation":[{"name":"Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulla","family":"Al-Rashdan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, BC Cancer, University of British Columbia, Victoria, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Wright","sequence":"additional","affiliation":[{"name":"University of North Carolina School of Medicine, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roumeliotis","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9503","key":"coi260030r1","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"issue":"9804","key":"coi260030r2","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"coi260030r3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ijrobp.2015.07.2292","article-title":"Exposure of the heart in breast cancer radiation therapy: a systematic review of heart doses published during 2003 to 2013.","volume":"93","author":"Taylor","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"coi260030r4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer.","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"coi260030r5","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.clon.2015.06.007","article-title":"Cardiac side-effects from breast cancer radiotherapy.","volume":"27","author":"Taylor","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"11","key":"coi260030r6","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","article-title":"Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures.","volume":"35","author":"van den Bogaard","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi260030r7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.semradonc.2015.09.003","article-title":"Contemporary breast radiotherapy and cardiac toxicity.","volume":"26","author":"Yeboa","year":"2016","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"coi260030r8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijrobp.2022.04.019","article-title":"Dose to the left anterior descending artery correlates with cardiac events after irradiation for breast cancer.","volume":"114","author":"Zureick","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"coi260030r9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00066-018-1378-z","article-title":"Heart toxicity from breast cancer radiotherapy: current findings, assessment, and prevention.","volume":"195","author":"Piroth","year":"2019","journal-title":"Strahlenther Onkol"},{"issue":"22","key":"coi260030r10","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1200\/JCO.2017.77.6351","article-title":"Cardiac structure injury after radiotherapy for breast cancer: cross-sectional study with individual patient data.","volume":"36","author":"Taylor","year":"2018","journal-title":"J Clin Oncol"},{"issue":"5","key":"coi260030r11","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.ijrobp.2011.03.009","article-title":"Anterior myocardial territory may replace the heart as organ at risk in intensity-modulated radiotherapy for left-sided breast cancer.","volume":"82","author":"Tan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"coi260030r12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13014-019-1242-z","article-title":"The relationship between radiation doses to coronary arteries and location of coronary stenosis requiring intervention in breast cancer survivors.","volume":"14","author":"Wennstig","year":"2019","journal-title":"Radiat Oncol"},{"issue":"5","key":"coi260030r13","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.ijrobp.2021.03.005","article-title":"Mean heart dose is an inadequate surrogate for left anterior descending coronary artery dose and the risk of major adverse cardiac events in lung cancer radiation therapy.","volume":"110","author":"Atkins","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"coi260030r14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/jamaoncol.2020.6332","article-title":"Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non-small cell lung cancer.","volume":"7","author":"Atkins","year":"2021","journal-title":"JAMA Oncol"},{"key":"coi260030r15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.radonc.2022.02.010","article-title":"Major adverse cardiac event risk prediction model incorporating baseline cardiac disease, hypertension, and logarithmic left anterior descending coronary artery radiation dose in lung cancer (CHyLL).","volume":"169","author":"Tjong","year":"2022","journal-title":"Radiother Oncol"},{"issue":"3","key":"coi260030r16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jaccao.2021.06.007","article-title":"Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification.","volume":"3","author":"Bergom","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"4","key":"coi260030r17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1120\/jacmp.v17i4.6188","article-title":"Evaluation of target and cardiac position during visually monitored deep inspiration breath-hold for breast radiotherapy.","volume":"17","author":"Conroy","year":"2016","journal-title":"J Appl Clin Med Phys"},{"key":"coi260030r18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13014-015-0511-8","article-title":"Cardiac dose reduction with deep inspiration breath hold for left-sided breast cancer radiotherapy patients with and without regional nodal irradiation.","volume":"10","author":"Yeung","year":"2015","journal-title":"Radiat Oncol"},{"key":"coi260030r19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s12609-019-00326-2","article-title":"Partial-Breast Irradiation.","volume":"11","author":"Manyam","year":"2019","journal-title":"Review of Modern Trials Curr Breast Cancer Rep"},{"issue":"3","key":"coi260030r20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.radonc.2017.12.021","article-title":"A simple clinical method for predicting the benefit of prone vs supine positioning in reducing heart exposure during left breast radiotherapy.","volume":"126","author":"Kah\u00e1n","year":"2018","journal-title":"Radiother Oncol"},{"issue":"35","key":"coi260030r21","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-Florence Trial.","volume":"38","author":"Meattini","year":"2020","journal-title":"J Clin Oncol"},{"issue":"3","key":"coi260030r22","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/j.prro.2017.09.009","article-title":"Five-field IMRT class solutions and dosimetric planning guidelines for implementing accelerated partial breast irradiation.","volume":"8","author":"Quirk","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"coi260030r23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.radonc.2020.04.022","article-title":"A retrospective analysis to demonstrate achievable dosimetry for the left anterior descending artery in left-sided breast cancer patients treated with radiotherapy.","volume":"148","author":"Quirk","year":"2020","journal-title":"Radiother Oncol"},{"issue":"3","key":"coi260030r24","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.clon.2016.11.005","article-title":"The UK HeartSpare Study (stage II): multicentre evaluation of a voluntary breath-hold technique in patients receiving breast radiotherapy.","volume":"29","author":"Bartlett","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"10237","key":"coi260030r25","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"coi260030r26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.prro.2022.08.016","article-title":"Consensus quality measures and dose constraints for breast cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.","volume":"13","author":"Puckett","year":"2023","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"coi260030r27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.adro.2019.01.001","article-title":"Nationwide trends in heart-sparing techniques utilized in radiation therapy for breast cancer.","volume":"4","author":"Desai","year":"2019","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"coi260030r28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.radonc.2013.06.025","article-title":"Inter-observer variation in delineation of the heart and left anterior descending coronary artery in radiotherapy for breast cancer: a multi-centre study from Denmark and the UK.","volume":"108","author":"Lorenzen","year":"2013","journal-title":"Radiother Oncol"},{"issue":"3","key":"coi260030r29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.radonc.2016.12.029","article-title":"Development of delineation for the left anterior descending coronary artery region in left breast cancer radiotherapy: an optimized organ at risk.","volume":"122","author":"Lee","year":"2017","journal-title":"Radiother Oncol"},{"issue":"4","key":"coi260030r30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.6004\/jnccn.2022.0021","article-title":"NCCN Guidelines Insights: Hodgkin lymphoma, version 2.2022.","volume":"20","author":"Hoppe","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"coi260030r31","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1002\/mp.14797","article-title":"Technical note: a standardized automation framework for monitoring institutional radiotherapy protocol compliance.","volume":"48","author":"Quirk","year":"2021","journal-title":"Med Phys"},{"issue":"40","key":"coi260030r32","doi-asserted-by":"publisher","first-page":"E1091","DOI":"10.1503\/cmaj.191040","article-title":"The SPOR Canadian Data Platform: opportunity for multi-provincial research.","volume":"191","author":"Guttmann","year":"2019","journal-title":"CMAJ"},{"key":"coi260030r33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-8-1","article-title":"An administrative data merging solution for dealing with missing data in a clinical registry: adaptation from ICD-9 to ICD-10.","volume":"8","author":"Southern","year":"2008","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"coi260030r34","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/jamaoncol.2020.7468","article-title":"Association of breast cancer irradiation with cardiac toxic effects: a narrative review.","volume":"7","author":"Meattini","year":"2021","journal-title":"JAMA Oncol"},{"issue":"10","key":"coi260030r35","first-page":"1225","article-title":"APPROACH Investigators. Overview of the Alberta Provincial project for outcome assessment in coronary heart disease.","volume":"16","author":"Ghali","year":"2000","journal-title":"Can J Cardiol"},{"issue":"6","key":"coi260030r36","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/s13054-014-0651-5","article-title":"Predicting cardiovascular intensive care unit readmission after cardiac surgery: derivation and validation of the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) cardiovascular intensive care unit clinical prediction model from a registry cohort of 10,799 surgical cases.","volume":"18","author":"van Diepen","year":"2014","journal-title":"Crit Care"},{"issue":"6","key":"coi260030r37","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.athoracsur.2013.06.052","article-title":"Coronary revascularization for patients with severe left ventricular dysfunction.","volume":"96","author":"Nagendran","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"coi260030r38","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jcct.2014.07.003","article-title":"SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee.","volume":"8","author":"Leipsic","year":"2014","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"4","key":"coi260030r39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/01.CIR.51.4.5","article-title":"A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.","volume":"51","author":"Austen","year":"1975","journal-title":"Circulation"},{"issue":"6","key":"coi260030r40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer.","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"coi260030r41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.clon.2012.07.012","article-title":"Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart.","volume":"25","author":"Appelt","year":"2013","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"coi260030r42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41746-021-00416-5","article-title":"Deep-learning system to improve the quality and efficiency of volumetric heart segmentation for breast cancer.","volume":"4","author":"Zeleznik","year":"2021","journal-title":"NPJ Digit Med"},{"key":"coi260030r43","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1016\/j.ijrobp.2023.06.345","article-title":"Deployment of a deep learning automated cardiac sub-structure contouring algorithm to measure coronary dose exposure trends in lung cancer radiation therapy.","volume":"117","author":"Guthier","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"coi260030r44","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.radonc.2017.01.008","article-title":"A cardiac contouring atlas for radiotherapy.","volume":"122","author":"Duane","year":"2017","journal-title":"Radiother Oncol"},{"issue":"23","key":"coi260030r45","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1002\/sim.4509","article-title":"Classification accuracy and cut point?selection.","volume":"31","author":"Liu","year":"2012","journal-title":"Stat Med"},{"issue":"10215","key":"coi260030r46","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"coi260030r47","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.ijrobp.2023.10.016","article-title":"Accelerated partial breast irradiation using 5 daily fractions: a prospective, phase 2, multicenter trial of cosmetic outcomes and toxicity\u2014ACCEL final results.","volume":"118","author":"Grendarova","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"coi260030r48","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1200\/JCO.21.02613","article-title":"Development and validation of risk prediction models for coronary heart disease and heart failure after treatment for Hodgkin lymphoma.","volume":"41","author":"de Vries","year":"2023","journal-title":"J Clin Oncol"},{"issue":"2","key":"coi260030r49","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ijrobp.2022.08.013","article-title":"Cardiac substructures dosimetric predictors for cardiac toxicity after definitive radiotherapy in esophageal cancer.","volume":"115","author":"Cai","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"coi260030r50","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025556","article-title":"Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol.","volume":"9","author":"Bekelman","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"coi260030r51","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.radonc.2017.03.012","article-title":"Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977-2005.","volume":"123","author":"Rehammar","year":"2017","journal-title":"Radiother Oncol"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2850972\/jamaoncology_quirk_2026_oi_260030_1789560640.19871.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:00:39Z","timestamp":1789657239000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2850972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2026.2066","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}